{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:53:31Z","timestamp":1793141611082,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":64,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.semnephrol.2024.151494","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:21:39Z","timestamp":1711513299000},"page":"151494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiology of Cancer in Kidney Transplant Recipients"],"prefix":"10.1016","volume":"44","author":[{"given":"David","family":"Massicotte-Azarniouch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ariana","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2024.151494_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0002","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41581-018-0022-6","article-title":"Cancer in kidney transplant recipients","volume":"14","author":"Au","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2017.08.038","article-title":"Infection and malignancy outweigh cardiovascular mortality in kidney transplant recipients: post hoc analysis of the FAVORIT trial","volume":"131","author":"Weinrauch","year":"2018","journal-title":"Am J Med."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0004","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000495081","article-title":"Trends in the causes of death among kidney transplant recipients in the United States (1996-2014)","volume":"48","author":"Awan","year":"2018","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/nep.13250","article-title":"Comparison of cause of death between Australian and New Zealand Dialysis and Transplant Registry and the Australian National Death Index","volume":"24","author":"Sypek","year":"2019","journal-title":"Nephrology (Carlton)."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0006","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ki.2013.458","article-title":"Malignancy-related mortality following kidney transplantation is common","volume":"85","author":"Farrugia","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1017498","article-title":"Skin cancer outcomes and risk factors in renal transplant recipients: analysis of organ procurement and transplantation network data from 2000 to 2021","volume":"12","author":"Hao","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0008","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/TP.0b013e31827743b4","article-title":"Time on dialysis and cancer risk after kidney transplantation","volume":"95","author":"Wong","year":"2013","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0009","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/TP.0000000000002178","article-title":"Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study","volume":"102","author":"Acuna","year":"2018","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.trre.2017.08.003","article-title":"Cancer recurrence after solid organ transplantation: a systematic review and meta-analysis","volume":"31","author":"Acuna","year":"2017","journal-title":"Transplant Rev (Orlando)."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0011","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ekir.2022.01.003","article-title":"Kidney transplant outcomes of patients with multiple myeloma","volume":"7","author":"Heybeli","year":"2022","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-022-00714-5","article-title":"Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through the International Kidney and Monoclonal Gammopathy Research Group","volume":"12","author":"Havasi","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0013","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990-2017","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0022","doi-asserted-by":"crossref","first-page":"e14019","DOI":"10.1111\/tid.14019","article-title":"Prevalence of cervical human papillomavirus and the risk of anal co-infection in kidney transplant recipients: results from a Danish clinical study","volume":"25","author":"Ring","year":"2023","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0015","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/ndt\/gfr769","article-title":"Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients","volume":"27","author":"Sampaio","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0023","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0000000000000375","article-title":"The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis","volume":"98","author":"Ma","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0027","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/ndt\/gfac337","article-title":"Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis","volume":"38","author":"Massicotte-Azarniouch","year":"2023","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0029","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","article-title":"Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation","volume":"76","author":"Cherikh","year":"2003","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.TP.0000442773.38510.32","article-title":"Acute rejection, T-cell-depleting antibodies, and cancer after transplantation","volume":"97","author":"Lim","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0014","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1399-3062.2011.00714.x","article-title":"Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy","volume":"14","author":"Hosseini-Moghaddam","year":"2012","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0016","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancies after kidney transplantation: Hong Kong renal registry","volume":"12","author":"Cheung","year":"2012","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0017","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ndt\/gfr277","article-title":"Malignancies after renal transplantation in Taiwan: a nationwide population-based study","volume":"27","author":"Li","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0018","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2019.04.014","article-title":"Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia","volume":"71","author":"Alavi","year":"2019","journal-title":"J Hepatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0019","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.2020.10121","article-title":"Hepatitis C-related hepatocellular carcinoma incidence in the Veterans Health Administration after introduction of direct-acting antivirals","volume":"324","author":"Beste","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0020","first-page":"171","article-title":"Dose-risk relationships between cigarette smoking and cervical cancer: a systematic review and meta-analysis","volume":"32","author":"Malevolti","year":"2023","journal-title":"Eur J Cancer Prev."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0021","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.7314\/APJCP.2015.16.9.3893","article-title":"Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies","volume":"16","author":"Liu","year":"2015","journal-title":"Asian Pac J Cancer Prev."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0024","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1097\/TP.0000000000004117","article-title":"Malignancies in deceased organ donors: the Spanish experience","volume":"106","author":"Mah\u00edllo","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/TP.0b013e318272df41","article-title":"Cancer transmission from organ donors\u2014unavoidable but low risk","volume":"94","author":"Desai","year":"2012","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0026","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1600-6143.2011.03565.x","article-title":"Donor-transmitted malignancies in organ transplantation: assessment of clinical risk","volume":"11","author":"Nalesnik","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0028","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0031","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0032","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.18632\/oncotarget.23841","article-title":"Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0033","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2014a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0034","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1111\/j.1600-6143.2010.03181.x","article-title":"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit","volume":"10","author":"Collett","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0036","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0037","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/cid\/ciac285","article-title":"Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls","volume":"75","author":"Larsen","year":"2022","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0038","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.kint.2020.10.018","article-title":"Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period","volume":"99","author":"Blosser","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib78","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De Novo Malignancies after Kidney Transplantation","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2024.151494_bib0039","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1681\/ASN.2018090906","article-title":"Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant","volume":"30","author":"Au","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada","volume":"2","author":"Acuna","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0041","first-page":"2433","article-title":"Cancer mortality among solid organ transplant recipients in the United States during 1987-2018","volume":"107","author":"Wang","year":"2023","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0042","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/TP.0000000000000760","article-title":"Cancer-specific and all-cause mortality in kidney transplant recipients with and without previous cancer","volume":"99","author":"Viecelli","year":"2015","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0043","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/TP.0b013e3181a238f6","article-title":"De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population","volume":"87","author":"Miao","year":"2009","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0044","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.3389\/ti.2022.10024","article-title":"Incidence and outcomes of early cancers after kidney transplantation","volume":"35","author":"Krishnan","year":"2022","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0045","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/tri.12638","article-title":"Reductions in immunosuppression after haematological or solid organ cancer diagnosis in kidney transplant recipients","volume":"28","author":"Hope","year":"2015","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0046","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.kint.2020.06.046","article-title":"KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer","volume":"98","author":"Porta","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0047","doi-asserted-by":"crossref","first-page":"406","DOI":"10.6004\/jnccn.2022.7009","article-title":"Immune checkpoint inhibitor use in solid organ transplant recipients: a systematic review","volume":"20","author":"Portuguese","year":"2022","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0048","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0049","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2369-14-137","article-title":"Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis\u2014an observational cohort study","volume":"14","author":"Skov Dalgaard","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0050","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.canep.2011.12.002","article-title":"Comparative incidence of cancer in HIV-AIDS patients and transplant recipients","volume":"36","author":"Oliveira Cobucci","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0051","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet."},{"issue":"suppl 3","key":"10.1016\/j.semnephrol.2024.151494_bib0052","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2288-2-11","article-title":"Statistical issues in randomized trials of cancer screening","volume":"2","author":"Baker","year":"2002","journal-title":"BMC Med Res Methodol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0054","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0056","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamadermatol.2019.0692","article-title":"Incidence and risk factors of keratinocyte carcinoma after first solid organ transplant in Ontario, Canada","volume":"155","author":"Park","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0057","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/ajkd.2003.50130","article-title":"Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia","volume":"41","author":"Carroll","year":"2003","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0058","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/jrms.JRMS_817_17","article-title":"Incidence of nonmelanoma skin cancer in renal transplant recipients: a systematic review and meta-analysis","volume":"23","author":"Matinfar","year":"2018","journal-title":"J Res Med Sci."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0059","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jaad.2005.10.049","article-title":"Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series","volume":"54","author":"Harwood","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0061","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmicb.2018.00117","article-title":"\u03b2-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort","volume":"9","author":"Borgogna","year":"2018","journal-title":"Front Microbiol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0062","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1096-9071(200007)61:3<289::AID-JMV2>3.0.CO;2-Z","article-title":"Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals","volume":"61","author":"Harwood","year":"2000","journal-title":"J Med Virol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0063","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1600-6143.2008.02392.x","article-title":"Molecular concepts of virus infections causing skin cancer in organ transplant recipients","volume":"8","author":"Nindl","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0064","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2133.1998.02079.x","article-title":"The compliance of renal transplant recipients with advice about sun protection measures","volume":"138","author":"Seukeran","year":"1998","journal-title":"Br J Dermatol."},{"issue":"suppl 3","key":"10.1016\/j.semnephrol.2024.151494_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0066","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.7164\/antibiotics.37.1231","article-title":"Activity of rapamycin (AY-22,989) against transplanted tumors","volume":"37","author":"Eng","year":"1984","journal-title":"J Antibiot (Tokyo)."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0067","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","article-title":"The role of mTOR inhibitors in the management of viral infections: a review of current literature","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0068","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0069","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results","volume":"36","author":"Dantal","year":"2018","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0070","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0071","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0072","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0073","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/tri.13952","article-title":"Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): an overview of the available evidence and guidance for shared decision-making","volume":"34","author":"Hellemans","year":"2021","journal-title":"Transpl Int."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0074","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4329\/wjr.v14.i3.60","article-title":"Immunosuppressive treatment and radiotherapy in kidney transplant patients: a systematic review","volume":"14","author":"Lancellotta","year":"2022","journal-title":"World J Radiol."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0075","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/jcm8122189","article-title":"Management of immunosuppression in kidney transplant recipients who develop malignancy","volume":"8","author":"Yang","year":"2019","journal-title":"J Clin Med."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0076","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(\u2605)","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1016\/j.semnephrol.2024.151494_bib0077","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.kint.2020.07.012","article-title":"KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation","volume":"98","author":"Ma\u0142yszko","year":"2020","journal-title":"Kidney Int."}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:51:13Z","timestamp":1748343073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929524000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0270929524000111"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151494","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Cancer in Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151494"}}